Navigation Links
Milli-Q Academic System (non-TOC)

ProductsMilli-Q Academic System (non-TOC)
Company Millipore
Item Milli-Q Academic System (non-TOC)
Features Inquire
Description Millipore has developed a range of Milli-Q ultrapure water systems designed to match specific water quality requirements. Each of the five new Milli-Q systems is designed to specifically target contaminants detrimental to particular applications such as HPLC, molecular biology and ICP-MS. The systems incorporate a high precision resistivity monitor that records conductivity or resistivity (compensated or not to 25 C), and also feature a built-in TOC monitor with a 1 999 ppb detection range for accurate analysis of organics. Milli-Q systems meet USP 24 requirements for resistivity and TOC suitability tests. Validation and qualification services are available, and the optional Explore Data software allows easy access to historical data via a computer interface for documenting GLP compliance. All systems can be bench-operated, wall-mounted or bench-integrated for maximizing space requirements.

All systems in the Milli-Q range employ a 3-step purification process:
Step 1:
Plug-in Q-Gard purification packs are tailored to the feedwater source to optimize the performance of downstream purification media to ensure consistent results.
Step 2:
Quantum application-specific cartridges remove ionic and organic contaminants down to trace levels.
Step 3:
Final purification of ultrapure water is carried out at the point-of-use by a pharmaceutical-grade, absolute 0.22 m Millipak membrane filter that is recommended for most analytical applications.

Info Millipore
Customer Service: (978) 715-4321
Web site: http://www.millipore.com/

Related medicine products :

1. Milli-Q Gradient A10 System
2. Milli-Q Gradient A10 bench-integrated system
3. Milli-Q Gradient System (non-TOC)
4. Milli-Q Gradient bench-integrated system (non-TOC)
5. Milli-Q Academic A10 bench-integrated system
6. Milli-Q Academic A10 System
7. Milli-Q Academic bench-integrated system (non-TOC)
8. Milli-Q Biocel A10 System
9. Milli-Q Biocel A10 bench-integrated system
10. Milli-Q Biocel System (non-TOC)
11. Milli-Q Biocel System bench-integrated system (non-TOC)
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products:
(Date:7/30/2014)... July 30, 2014 Shabaikai is an ... forests of the Pomo Indians located on the shores ... the river Shabaikai, meaning ‘crooked snake’. Clarkson takes the ... and the violence of prohibition and organized crime, providing ... River. Here, the most powerful men in the world ...
(Date:7/30/2014)... Antonio, TX (PRWEB) July 30, 2014 ... with Christus Spohn Health, recently announced the proposed naming ... TX: the Dr. Hector P. Garcia Family Health Center. ... state-of-the-art primary health care services, including comprehensive chronic disease ... It will also be a pioneering medical home model ...
(Date:7/30/2014)... July 30, 2014 Naomi Fried, ... the Board of Directors of the American Telemedicine ... the Association, which has a mission to promote ... through telecommunications and information technology. , “Both Naomi ... Association, possess extraordinary expertise and are well known ...
(Date:7/30/2014)... have identified a protein that could help doctors decide ... that makes radiotherapy more effective, according to a study* ... (BJC). , The team from The University of Manchester, ... whose bladder tumour had high levels of a protein, ... carbogen oxygen mixed with carbon dioxide gas ...
(Date:7/30/2014)... Rhode Island Hospital researchers have found that a ... reduce depression and other symptoms in informal caregivers, ... dementia. The study is published online in advance ... Dementia . , "Those caring for people with ... often under a great deal of pressure," said ...
Breaking Medicine News(10 mins):Health News:Bill E. Clarkson Releases Debut Fact-Based Novel, Shabaikai 2Health News:Dr. Hector P Garcia Memorial Foundation Supports New Health Care Facility 2Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Scientists pinpoint bladder cancer patients who could benefit from 'tumor-softening' treatment 2Health News:Study: Telephone support program beneficial for caregivers of those with dementia 2
... A paper by Indiana University-Purdue University Indianapolis ... to improve identification of breast cancer tissue by ... scientific paper in the "bioinformatics and biomedical applications ... The best scientific paper award ...
... "fused" with a groupa bond even stronger than group identificationwill ... outsiders, conclude researchers in a new study published in ... Science. This intense bond to a group may help explain ... B. Swann, Jr., of the University of Texas, came up ...
... and adolescents have become fatter over the last ... Bloomberg School of Public Health and National Institute ... across socio-demographic groups over time and found U.S. ... such as body mass index (BMI), waist circumference ...
... and women in the Troms Study in northern Norway has reported ... cognitive tests. The subjects (average age 58 and free of ... with a range of cognitive function tests. Among women, there was ... consumed wine at least 4 or more times over two ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Aug. ... of imaging to guide the needle now make up the majority ... the use of these minimally invasive biopsies increased from 59 percent ... trend which is likely to continue, one expert noted. A biopsy ...
... (CLASS) Act a largely overlooked component of the 2010 ... to transform long-term care financing in the United States from ... issue of Public Policy & Aging Report ... SCAN Foundation , this installment of PPAR features ...
Cached Medicine News:Health News:People with 'fused' identities are willing to die for their social group 2Health News:Overweight American children and adolescents becoming fatter 2Health News:Moderate drinking, especially wine, associated with better cognitive function 2Health News:Less Invasive Biopsies Gain Favor 2Health News:CLASS Act analysis reveals America's long-term care future 2
(Date:7/30/2014)... , July 30, 2014   Unique Pizza ... Inc.: OTC Pink: UPZS), a Delaware Corporation, is ... agreement with Larasan Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical ... to the agreement, US-based Larasan will work with ... frozen pizza through Larasan,s vast distribution network throughout ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... Coordinators, Inc. (PCI) is pleased to announce it has ... Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug development ... manufacturing, as well as Clinical Packaging, Labeling, and global ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5